Abstract: Workshop Report: Outcome Measures for Sjögren's Syndrome, April 10-11, 2003, Bethesda, Maryland, USA

Outcome Measures for Sjögren's Syndrome,
April 10-11, 2003, Bethesda, Maryland, USA

STANLEY R. PILLEMER, JANINE SMITH, PHILIP C. FOX, and SIMON J. BOWMAN

From the Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research, National Institutes of Health (NIH), Bethesda; MedImmune, Gaithersburg, MD; the National Eye Institute, NIH, Bethesda; Department of Oral Medicine, Carolinas Medical Center, Charlotte, NC; and the Rheumatology Department, University of Birmingham, Birmingham, UK.

Supported by The Sjögren's Syndrome Foundation; the National Institute of Dental and Craniofacial Research; the National Eye Institute; the Office of Research on Women's Health; Allergan, Inc.; Daiichi Pharmaceutical Corporation; and MGI Pharma, Inc.

S.R. Pillemer, MD, Gene Therapy and Therapeutics Branch, NIDCR, NIH, and Director, Clinical Development, Immunological and Inflammatory Diseases, MedImmune, Gaithersburg, MD; J. Smith, MD, National Eye Institute; P.C. Fox, DDS, Visiting Scientist, Carolinas Medical Center; S.J. Bowman, FRCP, Rheumatology Department, University of Birmingham.

WORKSHOP CO-CHAIRS: S.R. Pillemer, MD, Gene Therapy and Therapeutics Branch, NIDCR, NIH, and Director, Clinical Development, Immunological and Inflammatory Diseases, MedImmune, Gaithersburg, MD; and S.J. Bowman, FRCP, Rheumatology Department, University of Birmingham, Birmingham, UK.

PARTICIPANTS: Elaine Alexander, MD, PhD, Consultant, Arena Pharmaceuticals, Inc., San Diego, CA, USA; Karsten Asmussen, MD, PhD, Department of Rheumatology, Rikshospitalet, Copenhagen, Denmark; Jane Atkinson, DDS, Dean of Clinical Affairs, University of Maryland, Baltimore, MD; Bruce J. Baum, Chief, Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research, NIH, Bethesda, MD, USA; Arthur Bookman, MD, FRCPC, Division of Rheumatology, Western Hospital, Toronto, ON, Canada; Steven Carsons, MD, Division of Rheumatology, Winthrop University Hospital, Mineola, NY; Troy Daniels, MS, DDS, Dean for Academic Affairs, School of Dentistry, San Francisco, CA; Gary Foulks, MD, University of Pittsburgh School of Medicine, Department of Ophthalmology, Pittsburgh, PA; Philip C. Fox, DDS, Visiting Scientist, Carolinas Medical Center, President-Elect, Sjögren's Syndrome Foundation, Cabin John, MD; Arthur Grayzel, MD, MACR, Mamaroneck, NY; John Harley, MD, PhD, Arthritis and Immunology Laboratory, Oklahoma Medical Research Foundation, Oklahoma City, OK, USA; Lennart Jacobsson, MD, PhD, Rheumatology, Lund University, Malmö University Hospital, Malmö, Sweden; Roland Jonsson, DMD, PhD, Professor, Broegelmann Research Laboratory, University of Bergen, Bergen, Norway; Stuart Kassan, MD, Clinical Professor of Medicine, University of Colorado Health Sciences Center, Denver, CO; Albert Kingman, PhD, Division of Population and Health Promotion Sciences, NIDCR, NIH, Bethesda, MD, USA; Haralampos Moutsopoulos, MD, FACP, Department of Pathophysiology, National University Medical School, Athens, Greece; Ann L. Parke, MB, Department of Rheumatology, University of Connecticut Health Center, Farmington, CT; Maureen Rischmueller, MD, Staff Consultant Rheumatologist, Rheumatology Department, The Queen Elizabeth Hospital, Woodville, SA, Australia; Oliver D. Schein, MD, MPH, Wilmer Ophthalmological Institute, Johns Hopkins Hospital, Baltimore, MD; Janine Smith, MD, National Eye Institute, NIH, Bethesda, MD; Nehad Solomon, MD, Division of Rheumatology, Winthrop University Hospital, Mineola, NY; Elke Theander, MD, Rheumatology, Lund University, Malmö University Hospital, Malmö, Sweden; Susan Vitale, PhD, National Eye Institute, Bethesda, MD; Claudio Vitali, MD, Chief, Department of Internal Medicine and Rheumatology, Ospedale "Villamarina" -Piombino, Livorno, Italy; Frederick Vivino, MD, The Penn Center for Primary Care; Presbyterian Medical Center, Philadelphia, PA.

Address reprint requests to Dr. S.R. Pillemer, Gene Therapy and Therapeutics Branch, National Institute of Dental and Craniofacial Research, 10 Center Drive, Rm IN113, MSC 1190, National Institutes of Health, Bethesda, Maryland 20892. E-mail: PillemerS@medimmune.com